GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Clinical trials for GERD (GASTROESOPHAGEAL REFLUX DISEASE) explained in plain language.
Never miss a new study
Get alerted when new GERD (GASTROESOPHAGEAL REFLUX DISEASE) trials appear
Sign up with your email to follow new studies for GERD (GASTROESOPHAGEAL REFLUX DISEASE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to outperform leading heartburn drug in Long-Term protection
Disease control Not yet recruitingThis study tests whether a new drug called linaprazan glurate works better than the approved drug lansoprazole at keeping the esophagus healed in people with chronic acid reflux disease (GERD). About 1,050 adults who have already healed their esophagus in a previous study will ta…
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated Apr 02, 2026 05:41 UTC
-
Surgeons test new method to prevent heartburn after achalasia surgery
Disease control Not yet recruitingThis study compares two versions of a minimally invasive throat surgery for achalasia, a rare swallowing disorder. Researchers want to see if preserving certain muscle fibers during the procedure reduces acid reflux afterward while still effectively treating the swallowing proble…
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: NA • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New pill aims to outperform standard heartburn drug in healing damaged esophagus
Disease control Not yet recruitingThis study is testing if a new drug called linaprazan glurate works better than the common medication lansoprazole at healing damage in the esophagus caused by severe acid reflux (GERD). About 500 adults with confirmed esophageal damage will be randomly assigned to take one of tw…
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: PHASE3 • Sponsor: Cinclus Pharma Holding AB • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC